HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antitampering bill

This article was originally published in The Rose Sheet

Executive Summary

House legislation to prohibit alteration of product identification codes amended in Judiciary/Courts and Intellectual Property Subcommittee with language similar to Senate version. Like its partner bill, HR 2100 now allows products to be repackaged, addressing a concern from wholesalers interested in discounting prices. In addition, the substitute language allows lawful diversion while prohibiting flea market sales. The Senate version, S 2105, was introduced Feb. 24 (1"The Rose Sheet" March 6, p. 4). The substitute bill, introduced by HR 2100 author Rep. Bob Goodlatte (R-Va.), passed the subcommittee 6-3 on March 23

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007831

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel